[Hemolytic disease of the newborn and therapeutic anti-allergic antibodies].
D000017:ABO Blood-Group System; D000577:Amides; D000700:Analgesics; D000906:Antibodies / Q000032:analysis*; D000941:Antigens; D001241:Aspirin; D001565:Benzoates; D004342:Drug Hypersensitivity / Q000276:immunology*; D004394:Dydrogesterone; D004899:Erythroblastosis, Fetal / Q000276:immunology* / Q000628:therapy; D005078:Exchange Transfusion, Whole Blood; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D011247:Pregnancy; D012204:Rh-Hr Blood-Group System; D012964:Sodium; D013267:Stilbenes
D000017:ABO Blood-Group System; D000577:Amides; D000700:Analgesics; D000906:Antibodies; D000941:Antigens; D001565:Benzoates; D012204:Rh-Hr Blood-Group System; D013267:Stilbenes; D004394:Dydrogesterone; D012964:Sodium; D001241:Aspirin
Maladie hémolytique néo-natale et anticorps médicamenteux allergiques.